Detalhe da pesquisa
1.
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial.
Eur Heart J
; 43(41): 4362-4373, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35900838
2.
An international cluster-randomized quality improvement trial to increase the adherence to evidence-based therapies for acute ischemic stroke and transient ischemic attack patients: Rationale and design of the BRIDGE STROKE Trial.
Am Heart J
; 207: 49-57, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30415083
3.
Regional differences in presentation and antithrombotic treatment of patients with atrial fibrillation: Baseline characteristics from a clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with atrial fibrillation (IMPACT-AF).
Am Heart J
; 192: 38-47, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28938962
4.
A clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AF): design and rationale.
Am Heart J
; 176: 107-13, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27264227
5.
Cardiovascular clinical research in South America.
Am Heart J
; 165(6): 848-53, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23708154
6.
[MANAGEMENT RECOMMENDATIONS FOR DIRECT ORAL ANTICOAGULANTS (DOACs) ANTI Xa AND ANTI IIa]. / RECOMENDACIONES DE MANEJO DE LOS ANTICOAGULANTES ORALES DIRECTOS (DOACS) ANTI Xa Y ANTI IIa.
Medicina (B Aires)
; 82 Suppl 2: 1-55, 2022 Mar.
Artigo
em Espanhol
| MEDLINE | ID: mdl-35344926
7.
Age, sex, and setting in the etiology of stroke study (ASSESS): Study design and protocol.
J Neurol Sci
; 399: 209-213, 2019 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30851659
8.
Recomendaciones de manejo de los anticoagulantes orales directos (DOACs) anti Xa y anti IIa / Recommendations for the practical management of the direct oral anticoagulants anti Xa and anti IIa
Medicina (B.Aires)
; 82(supl.2): 1-55, abr. 2022. graf
Artigo
em Espanhol
|
LILACS-Express
| ID: biblio-1375898
9.
Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes.
Eur Heart J
; 25(10): 859-66, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15140534